INO Financial Facts

General and administrative: 5.76M
Net loss: -20.76M
See Full Income Statement

Total stockholders' equity: 146.98M
Accounts receivable: 17.46M
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 8/10/21 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -9.1% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS -6.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/10/21 Q121 N/A-$0.18 N/A N/A$850K N/A N/A N/A
3/1/21 Q420 -$0.14-$0.22 +$0.08$5.6M$1.11M N/A Details
11/9/20 Q320 N/A-$0.19 N/A N/A$3.05M N/A N/A N/A
8/10/20 Q220 -$0.83N/A N/A $237K$135.7K N/A Details
5/11/20 Q120 -$0.26-$0.22 -$0.04$1.33M$1.91M N/A Details
3/12/20 Q419 -$0.38-$0.24 -$0.14$279K$2.32M N/A Details
11/12/19 Q319 -$0.25-$0.26 +$0.01$866.86K$3.93M N/A Details
8/8/19 Q219 -$0.30-$0.27 -$0.03$135.67K$5.66M N/A Details